Gordon J. Lutz;Melanie K. Tallent;Nicole Michele Lykens
发明人:
Gordon J. Lutz,Melanie K. Tallent,Nicole Michele Lykens
申请号：
US13144409
公开号：
US20120316223A1
申请日:
2010.01.14
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention encompasses a class of compounds known as splice modulating oligonucleotides (SMOs) that modulate pre-mRNA splicing, thereby affecting expression and functionality of a specific protein in a cell. The present invention further provides compositions and methods for modulating pre-mRNA splicing using a SMO of the invention to abrogate disease-causing mutations in a protein. Accordingly, the present invention provides compositions and methods of treating a subject at risk of, susceptible to, or having a disease, disorder, or condition associated with aberrant or unwanted target pre-mRNA expression or activity.
